These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25662489)

  • 1. A high-efficiency, low-toxicity, phospholipids-based phase separation gel for long-term delivery of peptides.
    Zhang T; Peng Q; San FY; Luo JW; Wang MX; Wu WQ; Gong T; Zhang ZR
    Biomaterials; 2015 Mar; 45():1-9. PubMed ID: 25662489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injectable and biodegradable phospholipid-based phase separation gel for sustained delivery of insulin.
    Zhang T; Luo J; Peng Q; Dong J; Wang Y; Gong T; Zhang Z
    Colloids Surf B Biointerfaces; 2019 Apr; 176():194-201. PubMed ID: 30616110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic study of a phospholipid-based phase separation gel for once a month administration of octreotide.
    Wang M; Shan F; Zou Y; Sun X; Zhang ZR; Fu Y; Gong T
    J Control Release; 2016 May; 230():45-56. PubMed ID: 27040814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymopentin-loaded phospholipid-based phase separation gel with long-lasting immunomodulatory effects: in vitro and in vivo studies.
    Zhang T; Qin XY; Cao X; Li WH; Gong T; Zhang ZR
    Acta Pharmacol Sin; 2019 Apr; 40(4):514-521. PubMed ID: 30002492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An injectable, low-toxicity phospholipid-based phase separation gel that induces strong and persistent immune responses in mice.
    Han L; Xue J; Wang L; Peng K; Zhang Z; Gong T; Sun X
    Biomaterials; 2016 Oct; 105():185-194. PubMed ID: 27522253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ Preparation of a Phospholipid Gel Co-Loaded with Methotrexate and Dexamethasone for Synergistic Rheumatoid Arthritis Treatment.
    Pu Q; Wang K; Peng B; Chen K; Gong T; Liu F; Yang Q
    Int J Nanomedicine; 2022; 17():5153-5162. PubMed ID: 36348765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in situ-forming phospholipid-based phase transition gel prolongs the duration of local anesthesia for ropivacaine with minimal toxicity.
    Li H; Liu T; Zhu Y; Fu Q; Wu W; Deng J; Lan L; Shi S
    Acta Biomater; 2017 Aug; 58():136-145. PubMed ID: 28611004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel doxorubicin-loaded in situ forming gel based high concentration of phospholipid for intratumoral drug delivery.
    Wu W; Chen H; Shan F; Zhou J; Sun X; Zhang L; Gong T
    Mol Pharm; 2014 Oct; 11(10):3378-85. PubMed ID: 24735404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone Phospholipid Gel for Intramuscular Administration Prepared by In Situ-Phase Separation.
    Dong N; Tang L; Zhao M; Zhang Y; Zhang Y; Yin T; He H; Gou J; Yuan Y; Tang X
    AAPS PharmSciTech; 2022 Nov; 23(8):294. PubMed ID: 36329305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide.
    Erfani Jabarian L; Rouini MR; Atyabi F; Foroumadi A; Nassiri SM; Dinarvand R
    Eur J Pharm Sci; 2013 Jan; 48(1-2):87-96. PubMed ID: 23131800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier.
    Hyun H; Kim YH; Song IB; Lee JW; Kim MS; Khang G; Park K; Lee HB
    Biomacromolecules; 2007 Apr; 8(4):1093-100. PubMed ID: 17326678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced anti-tumor and anti-metastasis efficacy against breast cancer with an intratumoral injectable phospholipids-based phase separation gel co-loaded with 5-fluotouracil and magnesium oxide by neutralizing acidic microenvironment.
    Yang L; Song X; Gong T; Wang L; Zhao T; Li L; Zhou C; Sun X; Zhang Z; Gong T
    Int J Pharm; 2018 Aug; 547(1-2):181-189. PubMed ID: 29864512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three in-situ gels composed of different oil types.
    Zhang P; Chen D; Tian Y; Li H; Gong T; Luo J; Ruan J; Gong T; Zhang Z
    Int J Pharm; 2020 Sep; 587():119707. PubMed ID: 32739391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injectable in situ forming gel based on lyotropic liquid crystal for persistent postoperative analgesia.
    Mei L; Xie Y; Huang Y; Wang B; Chen J; Quan G; Pan X; Liu H; Wang L; Liu X; Wu C
    Acta Biomater; 2018 Feb; 67():99-110. PubMed ID: 29225151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Injectable Gel Platform for the Prolonged Therapeutic Effect of Pitavastatin in the Management of Hyperlipidemia.
    Xiang N; Zhou X; He X; Zhang Y; Zhang J; Zhang ZR; Sun X; Gong T; Fu Y
    J Pharm Sci; 2016 Mar; 105(3):1148-55. PubMed ID: 26886326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson's disease.
    Jiang Y; Zhang X; Mu H; Hua H; Duan D; Yan X; Wang Y; Meng Q; Lu X; Wang A; Liu W; Li Y; Sun K
    Drug Deliv; 2018 Nov; 25(1):143-152. PubMed ID: 29275639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient weapon for protracted warfare to malaria: A chondroitin sulfate derivates-containing injectable, ultra-long-lasting meshy-gel system.
    Luo J; Zhang P; Liu R; Li X; Hua P; Li S; Zhang T; Zhang T; Fu Y; Song X; Gong T; Zhang Z
    Carbohydr Polym; 2019 Jun; 214():131-141. PubMed ID: 30925981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of microemulsions as prolonged-release injectables through in-situ phase transition.
    Wu Z; Alany RG; Tawfeek N; Falconer J; Zhang W; Hassan IM; Rutland M; Svirskis D
    J Control Release; 2014 Jan; 174():188-94. PubMed ID: 24316265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release Characteristics In Vitro and In Vivo of In Situ Gels for a Novel Peptide Compared with Low-Molecular-Weight Hydrophilic Drug.
    Zhang G; Hu J; Meng Q; Wang T; Yang X; Gao L; Quan D
    Curr Drug Deliv; 2017; 14(1):47-53. PubMed ID: 27440072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesicular phospholipid gels using low concentrations of phospholipids for the sustained release of thymopentin: pharmacokinetics and pharmacodynamics.
    Zhong Y; Chen L; Zhang Y; Li W; Sun X; Gong T; Zhang Z
    Pharmazie; 2013 Oct; 68(10):811-5. PubMed ID: 24273885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.